慢性前列腺炎/慢性骨盆疼痛综合征治疗新进展

慢性前列腺炎(CP)尤其是慢性前列腺炎/慢性骨盆疼痛综合征(CP/CPPS)(Ⅲ型)的发病机制至今尚不完全清楚,人群发病率可达2.5%~16.0%,为50岁以下男性最常见的泌尿外科疾病。20世纪90年代以来,在美国国立卫生研究院慢性前列腺炎协作研究网(NIH-CPCRN)、国际前列腺炎协作网(IPCN)等国际研究机构的协调下,各国研究者对CP的病因、诊断、治疗等诸方面进行了较以往更大规模的深入研究。CPPS是CP中最常见的也是疗效最差的一种类型,本文综述了近几年来CP/CPPS治疗新进展,探讨了其目前治疗所面临的主要问题及可能的原因,并对CP/CPPS治疗的前景予以展望。

Advances in the Treatment of Chronic Prostatitis/Chronic Pelvic Pain Syndrome

So far the etiology of chronic prostatitis(PC) and particularly chronic pelvic pain syndrome(CPPS) remains to be elucidated.According to recent epidemiologic data,CP is the most common urological disease in men below 50 years and occurs in 2.5%-16.0% of the world population.Since the 1990s,researchers of many countries have carried out deeper,more extensive and larger scaled studies than ever before on the etiology,diagnosis and treatment of the disease,with the sponsorship and coordination of such internat...